The FTSE 100 index has topped last week’s intraday record of 8692 after the benchmark posted a rise of 0.8% or 69.93 points ...

AstraZeneca could face a fine of up to $4.5 million in China over suspected unpaid taxes related to the import of two of its ...

Drugmaker AstraZeneca has warned it could face a fine in China over possible unpaid import taxes, as it revealed strong sales ...

Chief executive Emma Walmsley said ministers must work with the sector to boost investment amid growing concerns about doing ...

European shares hovered near a record high on Thursday, buoyed by a raft of upbeat earnings, including drugmaker AstraZeneca, ...

AstraZeneca overcame a drop in sales in China and the arrest of its top executive in the country to deliver an 18 per cent increase in revenues in the final quarter 2024. The London-listed company ...

AstraZeneca Plc reported better-than-expected profit and sales in the fourth quarter and forecast further gains as the UK drugmaker’s blockbuster cancer drugs offset weakened China sales.

Astrazeneca's revenue jumped 21 per cent last year as the pharmaceutical recorded broad growth across its key businesses.

The pharmaceuticals major was boosted by high demand for its key drugs that offset a slight sales drop in China.

AstraZeneca said on Thursday it has received a notice in China over unpaid taxes related to the import of two cancer ...